People with diabetes are at increased risk for heart disease. Cardiovascular disease is the leading cause of death in type 1 diabetes, and its burden is also increasing...

Researchers at the 2023 ATTD conference discussed research findings about hypoglycemia and potential solutions for resolving low blood sugar events.

Researchers at ATTD 2023 discussed some of the latest advancements in non-invasive glucose monitoring, including two new approaches to tackling this challenge.

A closed-loop system enables your CGM to communicate with your insulin pump to adjust your insulin dosage throughout the day. Researchers at ATTD 2023 presented the...

At the ATTD 2023 conference, panelists during the #dedocº Symposium highlighted how access and personalization impacts people with diabetes’ uptake and use of diabetes...

Researchers at the 2023 ATTD conference discussed the challenge of keeping up with insulin requirements in women with type 1 diabetes during pregnancy. After reviewing...

The low-cost drug verapamil, a widely available generic drug for blood pressure, was shown to preserve insulin-producing beta cell function in young people, aged 7-17,...

Researchers at this week’s 2023 Advanced Technologies and Treatments for Diabetes (ATTD) conference in Berlin provided an update on icodec and efsitora, two new basal...

Leading clinicians at the ATTD conference discussed the need for greater CGM access for people with type 2 diabetes, as well as those with cystic fibrosis-related...

The diaTribe team is headed to Berlin, Germany, to cover this year’s Advanced Technologies and Treatments for Diabetes (ATTD) conference! Here’s a preview of some...

The diaTribe Foundation hosted a day of lively discussions on standardizing and implementing outcomes #BeyondA1c in drug development, FDA approval, research, and access...

Diabetes experts make new recommendations to treat high blood glucose in people with type 2 diabetes. New guidelines focus on factors such as language use, sleep, and...

About 200 million people with diabetes around the world require daily insulin. Once-weekly basal insulins, if approved, could require fewer injections and potentially...

Preventing type 1 diabetes – the main goal for some who do not believe a cure is possible – would ultimately bring this ancient disease to its end. The world’s top...

A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...

The Diabetes Education Study Group (DESG) hosted a panel at this year’s EASD in which panelists provided an overview of recent evidence supporting education about...

diaTribe is excited to bring you additional expanded coverage from the EASD 2022 conference! Hear from leading clinicians and researchers around the world on insights...

Kelly Close and Adam Brown led two panels on next-generation diabetes at The diaTribe Foundation’s third annual gathering during ADA 2018; plus highlights from the “...

The diaTribe Learn team is headed to Stockholm, Sweden, to cover the latest news in diabetes research, drug development, care, and technology being presented at this...

Lyfebulb-Novo Nordisk Innovation Summit celebrates innovations in diabetes care developed by and for people with diabetes